期刊文献+

PIK3CA基因与结直肠癌发生发展的研究 被引量:1

Role of PIK3CA gene in colorectal cancer genesis and development
原文传递
导出
摘要 PIK3CA基因编码蛋白激酶P13K的p100a亚单位,参与P13K的合成,通过下游P13K/AKT通路发挥其生物学效应。多种肿瘤组织中可检测到PIK3CA基因突变,突变的PIK3CA异常激活P13K—AKT信号通路,导致细胞周期异常、细胞黏附性下降、细胞凋亡下调及新生血管形成等,促进肿瘤发生发展。研究表明PIK3CA与结直肠癌的发生、发展、分化、转移及耐药密切相关,有望在结直肠癌的早期诊断、基因筛查、治疗方案制定、复发随访等方面提供一定的临床证据。 ] The PIK3CA gene codes pl00c~, the catalytic subunit of phosphatidylinositol 3-kinase (PI3K) and is involved in the initiating the PI3K/AKT pathway. PIK3CA plays its biological roles through. downstream PI3K pathway. PIK3CA gene mutants can be detected in many kinds of tumors. The mutant PIK3CA gene can aLmormally activate PI3K pathway, leading to the abnormal cell cycle, decreased cell adhe- sion, down regulated apoptosis and neovascularization, and then promotes tumor genesis and development. Recent researches have found that mutant PIK3CA gene is closely correlated with the genesis, development, differentiation, metastasis and drug resistance of colorectal cancer. Research of PIK3CA in colorectal cancer may provide significant evidence for the early diagnosis, gene screen, therapeutic regimen making, recurrence and follow up.
出处 《国际肿瘤学杂志》 CAS 2012年第9期693-696,共4页 Journal of International Oncology
关键词 结直肠肿瘤 PI3K信号通路 Colorectal Neoplasms PI3K pathway
  • 相关文献

参考文献23

  • 1Volinia S, Hiles I, Omondoryd E, et al. Molecular-cloning. cDNA sequence, and chromosomal localization of the human phosphatidyli- nositol 3-kinase pl00 alpha(PIK3CA) gene. Genomics, 1994, 24 (3) :472-479.
  • 2Broderick DK, Di C, Parrett TJ, et al. Mutation of PIK3CA in ana- plastic oligodendrogliomas, high-grade astrncytomas, and medullo- blastomas. Cancer Res, 2004, 64(15) :5048-5050.
  • 3Rameh LE, Cantley LC. The role of phosphatidylinositol 3-kinase lipid products in cell function. J Biol Chem, 1999, 274(13) :8347- 8350.
  • 4Armaghany T, Wilson JD, Chu Q. Genetic alterations in colorectal cancer. Gastrointest Cancer Res, 2012, 5 ( 1 ) : 19-27.
  • 5Troxell ML, Brunner AL, Neff T, et al. Phosphatidylinositol-3-kinase pathway mutations are common in breast columnar cell lesions. Mod Patho, 2012, 30 ( 10 ) : 1038-1055.
  • 6van Eijk R, Licht J, Schrumpf M, et al. Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR. PLoS One,2011, 6(3):e17791.
  • 7Yamamoto S, Tsuda H, Takano M, et al. PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma. J Pathol, 2011,225(2) :189-194.
  • 8Rodriguez-Viciana P, Wame PH, Dhand R, et al. Phosphatidylinosi- tol-3-OH kinase as a direct target of ras. Nature( Lond), 1994, 370 (6490) :527-532.
  • 9Cantley LC. The phosphoinositide 3-kinase pathway. Science, 2002, 296(5573 ) : 1655-1657.
  • 10Liao X, Morikawa T, Lochhead P, et al. Prognostic role of PIK3CA mutation in colorectal cancer: cohort study and literature review. Clin Cancer Res, 2012, 18(8) :2257-2268.

同被引文献21

  • 1Wu K,Chang Q,Lu P,et al.Gefitinib resistance resulted from STAT3-mediated Akt activation in lung cancer cells[J].Oncotarget,2013,4(12):2430-2438.
  • 2Boreddy SR,Pramanik KC,Srivastava SK.Pancreatic tumor suppression by benzyl isothiocyanate is associated with inhibition of PI3K/Akt/FOXO pathway[J].Clin Cancer Res,2011,17 (7):1784-1795.
  • 3Cheng X,Xia W,Yang JY,et al.Activation of MDM2 by Akt in mammary epithelium delays mammary involution and accelerates mammary tumorigenesis[J].Cancer Res,2010,70(19):7684-7689.
  • 4Koti M,Gooding RJ,Nuin P,et al.Identification of the IGF1/PI3K/NF-kB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer[J].BMC Cancer,2013,13:549.
  • 5Zhang HR,Chen JM,Zeng ZY,et al.Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/Akt activity[J].J Int Med Res,2013,41(3):584-595.
  • 6Juengel E,Makarevi (c) J,Tsaur I,et al.Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo[J].PLoS One,2013,8(1):1-6.
  • 7He C,Sun XP,Qiao H,et al.Downregnlating hypoxia-inducible factor-2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma[J].Cancer Sci,2012,103 (3):528-534.
  • 8Kilic-Eren M,Boylu T,Tabor V.Targeting PI3K/Akt represses Hypoxia inducible factor-1 alpha activation and sensitizes Rhabdomyosarcoma and Ewing's sarcoma cells for apoptosis[J].Cancer Cell Int,2013,13(1):36.
  • 9Sakamoto KM,Frank DA.CREB in the pathophysiology of cancer:implications for targeting transcription factors for cancer therapy[J].Clin Cancer Res,2009,15 (8):2583-2587.
  • 10Chou CH,Lai SL,Chen CN,et al.IL-6 regulates Mcl-1L expression through the JAK/PI3K/Akt/CREB signaling pathway in hepatocytes:implication of an anti-apoptotic role during liver regeneration[J].PLoS One,2013,8(6):e66268.

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部